Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

Amplimmune (United States)

ROR OpenAlex
Research works
54
▼ 91% vs 2018-21
Citations
3.3k
61.2 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
34%
world 40%
International
32%
world 18%
Amplimmune (United States)

Not ranked overall: Amplimmune (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Amplimmune (United States) work in?

In all years, 48% of research at Amplimmune (United States) is in Health Sciences, 43% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (17%). It does 2.4× the world's share of Life Sciences.

Health Sciences: 26 fractional works · 48.2% of its workMedicine: 25 fractional works · 46.2% of its workOncology: 6 fractional works · 10.5% of its workEpidemiology: 4 fractional works · 7.2% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.8% of its workInfectious Diseases: 2 fractional works · 3.5% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.9% of its workRheumatology: 1 fractional works · 2.6% of its workPhysiology: 1 fractional works · 1.9% of its workSurgery: 1 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.7% of its workPathology and Forensic Medicine: 1 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.4% of its workGenetics: 1 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.1% of its workHealth Professions: 1 fractional works · 1.3% of its workMedical Laboratory Technology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 23 fractional works · 43.0% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 22.1% of its workMolecular Biology: 7 fractional works · 13.6% of its workCancer Research: 2 fractional works · 3.1% of its workBiotechnology: 1 fractional works · 2.0% of its workGenetics: 1 fractional works · 1.8% of its workCell Biology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 9 fractional works · 16.8% of its workImmunology: 9 fractional works · 15.9% of its workVirology: 0 fractional works · 0.3% of its workParasitology: 0 fractional works · 0.3% of its workMicrobiology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.6% of its workAgronomy and Crop Science: 1 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.3% of its workToxicology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workPhysical Sciences: 4 fractional works · 7.6% of its workEngineering: 2 fractional works · 3.5% of its workBiomedical Engineering: 2 fractional works · 3.5% of its workChemistry: 1 fractional works · 1.4% of its workSpectroscopy: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.2% of its workEcology: 0 fractional works · 0.6% of its workWater Science and Technology: 0 fractional works · 0.6% of its workComputer Science: 0 fractional works · 0.7% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.4% of its workHealth: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workALL ITS WORKAmplimmune(United States)54fractional works, all years
Life Sciences43%Physical Sciences8%Health Sciences48%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine2546.2%
    2. Health Professions11.3%
    3. Nursing00.3%
    4. Veterinary00.3%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology1222.1%
    2. Immunology and Microbiology916.8%
    3. Agricultural and Biological Sciences11.6%
    4. Neuroscience11.3%
    5. Pharmacology, Toxicology and Pharmaceutics11.3%
    1. Engineering23.5%
    2. Chemistry11.4%
    3. Environmental Science11.2%
    4. Computer Science00.7%
    5. Mathematics00.4%
    6. Materials Science00.3%
    7. Earth and Planetary Sciences00.1%
    1. Economics, Econometrics and Finance00.5%
    2. Social Sciences00.4%
    3. Decision Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Amplimmune (United States)?

The most cited paper from Amplimmune (United States) is "New use of BCG for recombinant vaccines" (C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al., 1991), with 1,513 citations. Next come "Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus" (647) and "CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade" (481).

Most cited papers
#PaperReleasedCitations
1 New use of BCG for recombinant vaccines C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature 6 Jun 1991 1,513
2 Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus Syd Johnson, Cynthia N. Oliver, Gregory A. Prince et al. · The Journal of Infectious Diseases Open access Nov 1997 647
3 CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade Limo Chen et al. · Cancer Discovery Open access 16 Jul 2018 481
4 Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery Suzanne I.S. Mosely et al. · Cancer Immunology Research 6 Dec 2016 439
5 Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses Timothy P. Welliver, Roberto P. Garofalo, Yashoda Madaiah Hosakote et al. · The Journal of Infectious Diseases Open access 15 Mar 2007 426
All 60 most cited papers, with filters and sorting

Which keywords describe research at Amplimmune (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Tumor Microenvironment, Inflammation, Immunotherapy and Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology8▲ 3.7×23 topics
  2. Inflammation5▲ 4.0×20 topics
  3. Monoclonal Antibodies5▲ 60×3 topics
  4. Therapeutic Antibodies4▲ 62×2 topics
  5. Glycosylation4▲ 33×3 topics
  6. Tumor Microenvironment4▲ 20×7 topics
  7. Cancer3▲ 4.2×13 topics
  8. Immunotherapy3▲ 8.7×12 topics
  9. Immunity3▲ 16×4 topics
  10. Biopharmaceuticals2▲ 68×3 topics
  11. Immune Response2▲ 7.5×12 topics
  12. Immunogenicity2▲ 86×2 topics
  13. Pathogenesis2▲ 8.0×5 topics
  14. Vaccine Development2▲ 14×4 topics
  15. Antibody Engineering2▲ 42×1 topic
  16. Fc Receptors2▲ 42×1 topic
  17. Cancer Immunotherapy2▲ 28×2 topics
  18. Recombinant Proteins2▲ 75×2 topics
  19. Protein Aggregation2▲ 48×1 topic
  20. Stability2▲ 20×1 topic
  21. Vaccine2▲ 9.6×6 topics
  22. Immune Checkpoint Blockade2▲ 62×1 topic
  23. Innate Immunity2▲ 10×4 topics
  24. Monoclonal Antibody2▲ 50×2 topics
  25. PD-1 and PD-L12▲ 62×1 topic
  26. Targeted Therapy2▲ 16×5 topics
  27. Human Metapneumovirus2▲ 71×1 topic
  28. Metabolism2▲ 5.0×8 topics
  29. Respiratory Syncytial Virus2▲ 71×1 topic
  30. Genomics2▲ 8.8×2 topics
  31. Respiratory2▲ 31×2 topics
  32. Virus2▲ 25×2 topics
  33. Autoantibodies2▲ 12×5 topics
  34. Dendritic Cells2▲ 26×2 topics
  35. Gene Therapy2▲ 11×3 topics
  36. Tumor Regression2▲ 34×2 topics
  37. Antibodies2▲ 31×2 topics
  38. Antigen Presentation2▲ 28×2 topics
  39. Autoimmunity2▲ 13×4 topics
  40. Cell Culture2▲ 25×2 topics

Which research topics does Amplimmune (United States) publish most on?

By volume in 2022-now: Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods, Receptor Mechanisms and Signaling and CAR-T cell therapy research.

Pharmacogenetics and Dru…0Pharmacogenetics and Drug Metabolism: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksReceptor Mechanisms and …0Receptor Mechanisms and Signaling: 0 fractional worksCAR-T cell therapy research: 0 fractional works
PharmacologyComputational Theory and MathematicsMolecular BiologyOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  3. 3 Receptor Mechanisms and Signaling Molecular Biology 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 0 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Ocular Oncology and Treatments Ophthalmology 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Ubiquitin and proteasome pathways Molecular Biology 0 works
  10. 10 Melanoma and MAPK Pathways Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.8%not open66.2%

World: 40% of research is openly available.

with international co-authors31.9%domestic only68.1%

World: 18% is written across borders.

How has Amplimmune (United States)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Amplimmune (United States) as a percentage of every work published that year, 0.0000026% in 2023.

still counting0.00010%0.00020%0.00030%Amplimmune (United States)0.0000090% in 2025200020102020

Fractional works of Amplimmune (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Amplimmune (United States). Posts are plain text and can be reported.